NTRK1 and cancer: Studies have shown that JS-K induces cancer cell apoptosis through the release of nitric oxide (NO), γ-interferon has immunomodulatory and anti-tumor cell proliferation effects, TP-0903 selectively inhibits Axl receptor tyrosine kinase, and gilteritinib has specific therapeutic effects on various FLT3 mutations5–8.